Press Releases Nunzia Pharmaceutical Company

Equities

NUNZ

US67097W1027

Market Closed - OTC Markets Other stock markets 01:10:00 02/12/2023 GMT			5-day change	1st Jan Change
0.003 ^USD	-.--%		-.--%	-.--%

2022	Nunzia Pharmaceutical Company Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	CI
2022	Nunzia Pharmaceutical Company Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	14/11/22	AQ
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	03/10/22	AQ
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23/05/22	AQ
NUNZIA PHARMACEUTICAL CO MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	15/04/22	AQ
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q/A)	29/03/22	AQ
Nunzia Pharmaceutical : Annual Report Late filing	28/03/22	PU
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	18/03/22	AQ
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	02/03/22	AQ
NUNZIA PHARMACEUTICAL CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	10/11/21	AQ
NUNZIA PHARMACEUTICAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	16/09/21	AQ
NUNZIA PHARMACEUTICAL : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	16/09/21	AQ
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	17/08/21	AQ
Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Now Offering a Patented Blood Warmer Through Nunzia's Medical Supply Division. 8K Filed 08/05/2021	16/08/21	AQ
Nunzia Pharmaceutical Corporation (OTC:NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, has Signed a Licensing Agreement with Michael Mitsunaga for the Exclusive Patent Rights to his IV BLOOD WARMER	06/08/21	AQ
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement (form 8-K)	04/08/21	AQ
NUNZIA PHARMACEUTICAL CO : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)	07/05/21	AQ
Nunzia Pharmaceutical Corporation, an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Proud to Start Studies on Anxiety-Based Tinnitus	05/05/20	GL
Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals	16/04/20	GL
Nunzia Pharmaceutical Corporation is an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals	14/04/20	GL
Nunzia Pharmaceutical : ARIZONA GOLD & ONYX MINING CO Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	02/12/19	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Nunzia Pharmaceutical Company

Equities

NUNZ

US67097W1027

Press Releases

Filters